Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLSD
DateTimeSourceHeadlineSymbolCompany
10/05/202421:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLSDClearside Biomedical Inc
09/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
09/05/202421:05GlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/05/202421:15GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
30/04/202412:05GlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
16/04/202412:05GlobeNewswire Inc.Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
02/04/202412:05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
18/03/202411:05GlobeNewswire Inc.Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical OfficerNASDAQ:CLSDClearside Biomedical Inc
12/03/202420:05GlobeNewswire Inc.Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
29/02/202412:05GlobeNewswire Inc.Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024NASDAQ:CLSDClearside Biomedical Inc
08/02/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
08/02/202421:52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLSDClearside Biomedical Inc
07/02/202413:00GlobeNewswire Inc.Clearside Biomedical Announces Pricing of $15 Million Registered Direct OfferingNASDAQ:CLSDClearside Biomedical Inc
01/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
19/01/202423:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
19/01/202420:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLSDClearside Biomedical Inc
28/12/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
14/12/202312:05GlobeNewswire Inc.Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
13/11/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
13/11/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
13/11/202321:05GlobeNewswire Inc.Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/11/202312:05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
07/11/202321:20GlobeNewswire Inc.Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
03/11/202316:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
03/11/202316:00GlobeNewswire Inc.BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®NASDAQ:CLSDClearside Biomedical Inc
02/11/202311:05GlobeNewswire Inc.Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
01/11/202311:05GlobeNewswire Inc.Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
31/10/202311:05GlobeNewswire Inc.Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023NASDAQ:CLSDClearside Biomedical Inc
16/10/202312:05GlobeNewswire Inc.Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific MeetingNASDAQ:CLSDClearside Biomedical Inc
04/10/202314:00GlobeNewswire Inc.Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific for Suprachoroidal Treatment of Uveitic Macular Edema as Partner Arctic Vision Completes Enrollment in Phase 3 Clinical Trial in ChinaNASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

Your Recent History

Delayed Upgrade Clock